LifeTech Scientific Corporation
LFTSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $7 | $7 | $8 | $7 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $6 | $7 | $7 | $6 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 4% | -0.3% | 4% | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 73.6% | 71.6% | 78.9% | 78.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 10.5% | 12.4% | 31.9% | 19.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.1% | 2.6% | 31.5% | 6.9% |
| EPS Diluted | 0.013 | 0.004 | 0.046 | 0.01 |
| % Growth | 225.6% | -91.6% | 371.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |